Endometrial stem/progenitor cells and their role in the pathogenesis of endometriosis.

Citation data:

Best practice & research. Clinical obstetrics & gynaecology, ISSN: 1532-1932, Vol: 50, Page: 27-38

Publication Year:
2018
Captures 6
Readers 6
Social Media 14
Tweets 14
PMID:
29503126
DOI:
10.1016/j.bpobgyn.2018.01.011
Author(s):
Cousins, Fiona L; O, Dorien F; Gargett, Caroline E
Publisher(s):
Elsevier BV
Tags:
Medicine
Most Recent Tweet View All Tweets
review description
Human endometrium regenerates on a cyclical basis each month, likely mediated by endometrial stem/progenitor cells. Several types of stem/progenitor cells have been identified: CD140bCD146 or SUSD2 endometrial mesenchymal stem cells (eMSCs), N-cadherin endometrial epithelial progenitor cells (eEPs), and side population (SP) cells, a heterogeneous population predominantly comprising endothelial cells. eMSCs reside in a perivascular niche and likely mediate angiogenesis and stromal regeneration. Human eEPs are located in the bases of glands in the basalis and are likely more primitive than SSEA-1 basalis epithelial cells. Endometrial stem/progenitor cells may contribute to the pathogenesis of endometriosis by their retrograde shedding into the pelvic cavity, either after menarche or as a result of neonatal uterine bleeding. eMSCs may have a role in the generation of progesterone-resistant phenotype of endometrial stromal fibroblasts (eSFs) in endometriosis. In future clinical practice, endometrial stem/progenitor cells may be used to establish diagnosis of endometriosis or as therapeutic targets.